Literature DB >> 32019336

Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors.

Chaozai Zhang1,2, Ruohan Zhu3, Qizhi Cao4, Xiaohong Yang2, Ziwei Huang1,3, Jing An1.   

Abstract

Entities:  

Keywords:  CXCR4; HIV-1 entry inhibitor; V3 loop; X4-tropic; gp120

Mesh:

Substances:

Year:  2020        PMID: 32019336      PMCID: PMC7082890          DOI: 10.1177/1535370220901498

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


× No keyword cloud information.
  77 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

2.  Discovery of novel N-aryl piperazine CXCR4 antagonists.

Authors:  Huanyu Zhao; Anthony R Prosser; Dennis C Liotta; Lawrence J Wilson
Journal:  Bioorg Med Chem Lett       Date:  2015-04-17       Impact factor: 2.823

3.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

4.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

Authors:  L Wu; N P Gerard; R Wyatt; H Choe; C Parolin; N Ruffing; A Borsetti; A A Cardoso; E Desjardin; W Newman; C Gerard; J Sodroski
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

5.  Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase.

Authors:  Bryan D Cox; Anthony R Prosser; Yongnian Sun; Zhufang Li; Sangil Lee; Ming B Huang; Vincent C Bond; James P Snyder; Mark Krystal; Lawrence J Wilson; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2015-05-06       Impact factor: 4.345

6.  Early cytoplasmic uncoating is associated with infectivity of HIV-1.

Authors:  João I Mamede; Gianguido C Cianci; Meegan R Anderson; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

7.  High affinity CXCR4 inhibitors generated by linking low affinity peptides.

Authors:  Chaozai Zhang; Lina S Huang; Ruohan Zhu; Qian Meng; Siyu Zhu; Yan Xu; Huijun Zhang; Xiong Fang; Xingquan Zhang; Jiao Zhou; Robert T Schooley; Xiaohong Yang; Ziwei Huang; Jing An
Journal:  Eur J Med Chem       Date:  2019-04-01       Impact factor: 6.514

8.  Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors.

Authors:  Chien-Huang Wu; Chuan-Jen Wang; Chun-Ping Chang; Yung-Chi Cheng; Jen-Shin Song; Jiing-Jyh Jan; Ming-Chen Chou; Yi-Yu Ke; Jing Ma; Ying-Chieh Wong; Tsung-Chih Hsieh; Yun-Chen Tien; Elizabeth A Gullen; Chen-Fu Lo; Chia-Yi Cheng; Yu-Wei Liu; Amit A Sadani; Chia-Hua Tsai; Hsin-Pang Hsieh; Lun K Tsou; Kak-Shan Shia
Journal:  J Med Chem       Date:  2015-01-28       Impact factor: 7.446

9.  Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131.

Authors:  Hirokazu Tamamura; Kenichi Hiramatsu; Satoshi Ueda; Zixuan Wang; Shuichi Kusano; Shigemi Terakubo; John O Trent; Stephen C Peiper; Naoki Yamamoto; Hideki Nakashima; Akira Otaka; Nobutaka Fujii
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

10.  Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells.

Authors:  Ming-Bo Huang; Kyle E Giesler; Brooke M Katzman; Anthony R Prosser; Valarie Truax; Dennis C Liotta; Lawrence J Wilson; Vincent C Bond
Journal:  Oncotarget       Date:  2018-02-26
View more
  4 in total

Review 1.  Role of CXCR4 in the progression and therapy of acute leukaemia.

Authors:  Long Su; Zheng Hu; Yong-Guang Yang
Journal:  Cell Prolif       Date:  2021-05-29       Impact factor: 6.831

Review 2.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

3.  Fejerlectin, a Lectin-like Peptide from the Skin of Fejervarya limnocharis, Inhibits HIV-1 Entry by Targeting Gp41.

Authors:  Weichen Xiong; Chenliang Zhou; Shuwen Yin; Jinwei Chai; Baishuang Zeng; Jiena Wu; Yibin Li; Lin Li; Xueqing Xu
Journal:  ACS Omega       Date:  2021-02-24

Review 4.  HIV-1 Entry and Membrane Fusion Inhibitors.

Authors:  Tianshu Xiao; Yongfei Cai; Bing Chen
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.